Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial

Clin Gastroenterol Hepatol. 2021 Jan;19(1):206-207. doi: 10.1016/j.cgh.2020.06.016.

Authors

Javier Del Hoyo¹, Mariam Aguas²

Affiliations

¹ Gastroenterology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
² Gastroenterology Department, La Fe University and Polytechnic Hospital, CIBEREHD (Networked Biomedical Research Center for Hepatic and Digestive Diseases), Health Research Institute, La Fe University Hospital, Valencia, Spain.

PMID: 33339564
DOI: 10.1016/j.cgh.2020.06.016

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost-Benefit Analysis
Humans
Inflammatory Bowel Diseases* / diagnosis
Inflammatory Bowel Diseases* / therapy
Telemedicine*